Role of the CTRP family in tumor development and progression (Review)
- Authors:
- Mowei Kong
- Yu Gao
- Xiang Guo
- Yuyu Xie
- Yamei Yu
-
Affiliations: Department of Endocrinology, Affiliated Hospital of Chengde Medical University, Chengde, Hebei 067000, P.R. China, Department of Respiratory, Affiliated Hospital of Chengde Medical University, Chengde, Hebei 067000, P.R. China, Department of Dermatology, Affiliated Hospital of Chengde Medical University, Chengde, Hebei 067000, P.R. China - Published online on: August 10, 2021 https://doi.org/10.3892/ol.2021.12984
- Article Number: 723
-
Copyright: © Kong et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
This article is mentioned in:
Abstract
 |
 |
 |
 |
|
Archambault AN, Su YR, Jeon J, Thomas M, Lin Y, Conti DV, Win AK, Sakoda LC, Lansdorp-Vogelaar I, Peterse EFP, et al: Cumulative burden of colorectal cancer-associated genetic variants is more strongly associated with early-onset vs. late-onset cancer. Gastroenterology. 158:1274–1286.e12. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Sagnelli E, Macera M, Russo A, Coppola N and Sagnelli C: Epidemiological and etiological variations in hepatocellular carcinoma. Infection. 48:7–17. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Işçi Bostanci E, Durmuş Y, Duru Çöteli SA, Kayikçioğlu F and Boran N: Outcomes of the conservative management of the patients with endometrial intraepithelial neoplasia/endometrial cancer: Wait or treat! Turk J Med Sci. May 20–2021.(Epub ahead of print). | |
|
Heyn GS, Corrêa LH and Magalhães KG: The impact of adipose tissue-derived miRNAs in metabolic syndrome, obesity, and cancer. Front Endocrinol (Lausanne). 11:5638162020. View Article : Google Scholar : PubMed/NCBI | |
|
Marino N, German R, Rao X, Simpson E, Liu S, Wan J, Liu Y, Sandusky G, Jacobsen M, Stoval M, et al: Upregulation of lipid metabolism genes in the breast prior to cancer diagnosis. NPJ Breast Cancer. 6:502020. View Article : Google Scholar : PubMed/NCBI | |
|
Philp LK, Rockstroh A, Lehman M, Sadowski MC, Bartonicek N, Wade JD, Otvos L and Nelson CC: Adiponectin receptor activation inhibits prostate cancer xenograft growth. Endocr Relat Cancer. 27:711–729. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Llanos AAM, Yao S, Singh A, Aremu JB, Khiabanian H, Lin Y, Omene C, Omilian AR, Khoury T, Hong CC, et al: Gene expression of adipokines and adipokine receptors in the tumor microenvironment: Associations of lower expression with more aggressive breast tumor features. Breast Cancer Res Treat. 185:785–798. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Wu X, Long X, Yang C, Chen H, Sharkey C, Rashid K, Hu M, Liu Y, Huang Q, Chen Q, et al: Icaritin reduces prostate cancer progression via inhibiting high-fat diet-induced serum adipokine in TRAMP mice model. J Cancer. 11:6556–6564. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wong GW, Krawczyk SA, Kitidis-Mitrokostas C, Revett T, Gimeno R and Lodish HF: Molecular, biochemical and functional characterizations of C1q/TNF family members: Adipose-tissue-selective expression patterns, regulation by PPAR-gamma agonist, cysteine-mediated oligomerizations, combinatorial associations and metabolic functions. Biochem J. 416:161–177. 2008. View Article : Google Scholar : PubMed/NCBI | |
|
Sarver DC, Stewart AN, Rodriguez S, Little HC, Aja S and Wong GW: Loss of CTRP4 alters adiposity and food intake behaviors in obese mice. Am J Physiol Endocrinol Metab. 319:E1084–E1100. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Shanaki M, Shabani P, Goudarzi A, Omidifar A, Bashash D and Emamgholipour S: The C1q/TNF-related proteins (CTRPs) in pathogenesis of obesity-related metabolic disorders: Focus on type 2 diabetes and cardiovascular diseases. Life Sci. 256:1179132020. View Article : Google Scholar : PubMed/NCBI | |
|
Rasooli Tehrani A, Gholipour S, Sharifi R, Yadegari S, Abbasi-Kolli M and Masoudian N: Plasma levels of CTRP-3, CTRP-9 and apelin in women with multiple sclerosis. J Neuroimmunol. 333:5769682019. View Article : Google Scholar : PubMed/NCBI | |
|
Kishore U, Gaboriaud C, Waters P, Shrive AK, Greenhough TJ, Reid KB, Sim RB and Arlaud GJ: C1q and tumor necrosis factor superfamily: Modularity and versatility. Trends Immunol. 25:551–561. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Schäffler A and Buechler C: CTRP family: Linking immunity to metabolism. Trends Endocrinol Metab. 23:194–204. 2012. View Article : Google Scholar | |
|
Wong GW, Wang J, Hug C, Tsao TS and Lodish HF: A family of Acrp30/adiponectin structural and functional paralogs. Proc Natl Acad Sci USA. 101:10302–10307. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Tan SY, Little HC, Sarver DC, Watkins PA and Wong GW: CTRP12 inhibits triglyceride synthesis and export in hepatocytes by suppressing HNF-4α and DGAT2 expression. FEBS Lett. 594:3227–3239. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Lei X and Wong GW: C1q/TNF-related protein 2 (CTRP2) deletion promotes adipose tissue lipolysis and hepatic triglyceride secretion. J Biol Chem. 294:15638–15649. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Moradi N, Najafi M, Sharma T, Fallah S, Koushki M, Peterson JM, Meyre D and Fadaei R: Circulating levels of CTRP3 in patients with type 2 diabetes mellitus compared to controls: A systematic review and meta-analysis. Diabetes Res Clin Pract. 169:1084532020. View Article : Google Scholar : PubMed/NCBI | |
|
Qian M, Yang Q, Li J, Zhao B, Zhang Y and Zhao Y: C1q/TNF-related protein-9 alleviates airway inflammation in asthma. Int Immunopharmacol. 81:1062382020. View Article : Google Scholar : PubMed/NCBI | |
|
Peterson JM, Wei Z and Wong GW: CTRP8 and CTRP9B are novel proteins that hetero-oligomerize with C1q/TNF family members. Biochem Biophys Res Commun. 388:360–365. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Schäffler A, Ehling A, Neumann E, Herfarth H, Paul G, Tarner I, Gay S, Schölmerich J and Müller-Ladner U: Genomic organization, promoter, amino acid sequence, chromosomal localization, and expression of the human gene for CORS-26 (collagenous repeat-containing sequence of 26-kDa protein). Biochim Biophys Acta. 1630:123–129. 2003. View Article : Google Scholar | |
|
Maeda T, Abe M, Kurisu K, Jikko A and Furukawa S: Molecular cloning and characterization of a novel gene, CORS26, encoding a putative secretory protein and its possible involvement in skeletal development. J Biol Chem. 276:3628–3634. 2001. View Article : Google Scholar : PubMed/NCBI | |
|
Byerly MS, Petersen PS, Ramamurthy S, Seldin MM, Lei X, Provost E, Wei Z, Ronnett GV and Wong GW: C1q/TNF-related protein 4 (CTRP4) is a unique secreted protein with two tandem C1q domains that functions in the hypothalamus to modulate food intake and body weight. J Biol Chem. 289:4055–4069. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Li Q, Wu J, Xi W, Chen X, Wang W, Zhang T, Yang A and Wang T: Ctrp4, a new adipokine, promotes the differentiation of osteoblasts. Biochem Biophys Res Commun. 512:224–229. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Kirketerp-Møller N, Bayarri-Olmos R, Krogfelt KA and Garred P: C1q/TNF-related protein 6 is a pattern recognition molecule that recruits collectin-11 from the complement system to ligands. J Immunol. 204:1598–1606. 2020. View Article : Google Scholar | |
|
Lei X, Seldin MM, Little HC, Choy N, Klonisch T and Wong GW: C1q/TNF-related protein 6 (CTRP6) links obesity to adipose tissue inflammation and insulin resistance. J Biol Chem. 292:14836–14850. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Akiyama H, Furukawa S, Wakisaka S and Maeda T: CTRP3/cartducin promotes proliferation and migration of endothelial cells. Mol Cell Biochem. 304:243–248. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Zhao G, Zhang L, Qian D, Sun Y and Liu W: miR-495-3p inhibits the cell proliferation, invasion and migration of osteosarcoma by targeting C1q/TNF-related protein 3. Onco Targets Ther. 12:6133–6143. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Glogowska A, Thanasupawat T, Beiko J, Pitz M, Hombach-Klonisch S and Klonisch T: Novel CTRP8-RXFP1-JAK3-STAT3 axis promotes Cdc42-dependent actin remodeling for enhanced filopodia formation and motility in human glioblastoma cells. Mol Oncol. May 7–2021.(Epub ahead of print). View Article : Google Scholar : PubMed/NCBI | |
|
Akiyama H, Furukawa S, Wakisaka S and Maeda T and Maeda T: Elevated expression of CTRP3/cartducin contributes to promotion of osteosarcoma cell proliferation. Oncol Rep. 21:1477–1481. 2009.PubMed/NCBI | |
|
Akiyama H, Furukawa S, Wakisaka S and Maeda T: Cartducin stimulates mesenchymal chondroprogenitor cell proliferation through both extracellular signal-regulated kinase and phosphatidylinositol 3-kinase/Akt pathways. FEBS J. 273:2257–2263. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Li JM, Zhang X, Nelson PR, Odgren PR, Nelson JD, Vasiliu C, Park J, Morris M, Lian J, Cutler BS and Newburger PE: Temporal evolution of gene expression in rat carotid artery following balloon angioplasty. J Cell Biochem. 101:399–410. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Hill CS and Treisman R: Transcriptional regulation by extracellular signals: Mechanisms and specificity. Cell. 80:199–211. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Seger R and Krebs EG: The MAPK signaling cascade. FASEB J. 9:726–735. 1995. View Article : Google Scholar : PubMed/NCBI | |
|
Coltella N, Manara MC, Cerisano V, Trusolino L, Di Renzo MF, Scotlandi K and Ferracini R: Role of the MET/HGF receptor in proliferation and invasive behavior of osteosarcoma. FASEB J. 17:1162–1164. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Bentov I, LeRoith D and Werner H: The WT1 Wilms' tumor suppressor gene: A novel target for insulin-like growth factor-I action. Endocrinology. 144:4276–4279. 2003. View Article : Google Scholar : PubMed/NCBI | |
|
Kim JY, Min JY, Baek JM, Ahn SJ, Jun HY, Yoon KH, Choi MK, Lee MS and Oh J: CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo. Bone. 79:242–251. 2015. View Article : Google Scholar : PubMed/NCBI | |
|
Fattovich G, Stroffolini T, Zagni I and Donato F: Hepatocellular carcinoma in cirrhosis: Incidence and risk factors. Gastroenterology. 127 (5 Suppl 1):S35–S50. 2004. View Article : Google Scholar : PubMed/NCBI | |
|
Jung YY, Um JY, Nasif O, Alharbi SA, Sethi G and Ahn KS: Blockage of the JAK/STAT3 signaling pathway in multiple myeloma by leelamine. Phytomedicine. Apr 15–2021.(Epub ahead of print). View Article : Google Scholar | |
|
Hang T, Yang L, Zhang X, Li J, Long F, Zhu N, Li Y, Xia J, Zhang Y, Zhang P, et al: Peroxisome proliferator-activated receptor γ improves pemetrexed therapeutic efficacy in non-squamous non-small cell lung cancer. Am J Transl Res. 13:2296–2307. 2021.PubMed/NCBI | |
|
Li Q, Wang L, Tan W, Peng Z, Luo Y, Zhang Y, Zhang G, Na D, Jin P, Shi T, et al: Identification of C1qTNF-related protein 4 as a potential cytokine that stimulates the STAT3 and NF-κB pathways and promotes cell survival in human cancer cells. Cancer Lett. 308:203–214. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Grivennikov S, Karin E, Terzic J, Mucida D, Yu GY, Vallabhapurapu S, Scheller J, Rose-John S, Cheroutre H, Eckmann L and Karin M: IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell. 15:103–113. 2009. View Article : Google Scholar : PubMed/NCBI | |
|
Xia Y, Shen S and Verma IM: NF-kappaB, an active player in human cancers. Cancer Immunol Res. 2:823–830. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Wang R, Shao X, Yang J, Liu Z, Chew L and Shao Y: Ginkgo biloba extract mechanism inhibits hepatocellular carcinoma through the nuclear factor-κB/p53 signaling pathway. J Environ Pathol Toxicol Oncol. 39:179–189. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yang YM, Kim SY and Seki E: Inflammation and liver cancer: Molecular mechanisms and therapeutic targets. Semin Liver Dis. 39:26–42. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Naugler WE, Sakurai T, Kim S, Maeda S, Kim K, Elsharkawy AM and Karin M: Gender disparity in liver cancer due to sex differences in MyD88-dependent IL-6 production. Science. 317:121–124. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Li Y, Ye L, Jia G, Chen H, Yu L and Wu D: C1q/TNF-related protein 4 induces signal transducer and activator of transcription 3 pathway and modulates food intake. Neuroscience. 429:1–9. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Yu H, Lee H, Herrmann A, Buettner R and Jove R: Revisiting STAT3 signalling in cancer: New and unexpected biological functions. Nat Rev Cancer. 14:736–746. 2014. View Article : Google Scholar : PubMed/NCBI | |
|
Balkwill F: TNF-alpha in promotion and progression of cancer. Cancer Metastasis Rev. 25:409–416. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Kim MJ, Lee W, Park EJ and Park SY: C1qTNF-related protein-6 increases the expression of interleukin-10 in macrophages. Mol Cells. 30:59–64. 2010. View Article : Google Scholar : PubMed/NCBI | |
|
Wang L, Liu Z, Duan L, Ma B and Sun Z: C1q tumor necrosis factor-related protein 6 (CTRP6) inhibits the proliferation and migration of ovarian cancer cells. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 31:1664–1668. 2015.(In Chinese). PubMed/NCBI | |
|
Wan X, Zheng C and Dong L: Inhibition of CTRP6 prevented survival and migration in hepatocellular carcinoma through inactivating the AKT signaling pathway. J Cell Biochem. 120:17059–17066. 2019. View Article : Google Scholar : PubMed/NCBI | |
|
Takeuchi T, Adachi Y and Nagayama T: Expression of a secretory protein CTRP6, a C1qTNF family member, in hepatocellular carcinoma. Anal Cell Pathol (Amst). 34:113–121. 2011. View Article : Google Scholar : PubMed/NCBI | |
|
Lin W, Chen X, Chen T, Liu J, Ye Y, Chen L, Qiu X, Chia-Hsien Cheng J, Zhang L, Wu J and Qiu S: C1QTNF6 as a novel diagnostic and prognostic biomarker for clear cell renal cell carcinoma. DNA Cell Biol. 39:1000–1011. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Milone M, Desiderio A, Velotti N, Manigrasso M, Vertaldi S, Bracale U, D'Ambra M, Servillo G, De Simone G, De Palma FDE, et al: Surgical stress and metabolic response after totally laparoscopic right colectomy. Sci Rep. 11:96522021. View Article : Google Scholar : PubMed/NCBI | |
|
James S, Aparna JS, Babu A, Paul AM, Lankadasari MB, Athira SR, Kumar SS, Vijayan Y, Namitha NN, Mohammed S, et al: Cardamonin attenuates experimental colitis and associated colorectal cancer. Biomolecules. 11:6612021. View Article : Google Scholar : PubMed/NCBI | |
|
Gou JX, Jiang XJ, Qu HX and Cui YX: Expression of Complement C1q/Tumor Necrosis Factor Related Protein 6 in Colon Cancer. J Gastroenterol Hepatol. 28:313–316. 2019. | |
|
Lei H, Wu D, Wang JY, Li L, Zhang CL, Feng H, Fu FY and Wu LL: C1q/tumor necrosis factor-related protein-6 attenuates post-infarct cardiac fibrosis by targeting RhoA/MRTF-A pathway and inhibiting myofibroblast differentiation. Basic Res Cardiol. 110:352015. View Article : Google Scholar : PubMed/NCBI | |
|
Xu E, Yin C, Yi X and Liu Y: Knockdown of CTRP6 inhibits high glucose-induced oxidative stress, inflammation and extracellular matrix accumulation in mesangial cells through regulating the Akt/NF-κB pathway. Clin Exp Pharmacol Physiol. 47:1203–1211. 2020. View Article : Google Scholar : PubMed/NCBI | |
|
Wang YP, Zhao YJ and Kong XL: A metalloproteinase of the disintegrin and metalloproteinases and the ThromboSpondin Motifs 6 as a novel marker for colon cancer: Functional experiments. Genet Mol Biol. 43:e201902662020. View Article : Google Scholar : PubMed/NCBI | |
|
Cao L, Tan W, Chen W, Huang H, He M, Li Q, Zhu X and Wang L: CTRP4 acts as an anti-inflammatory factor in macrophages and protects against endotoxic shock. Eur J Immunol. 51:380–392. 2021. View Article : Google Scholar : PubMed/NCBI | |
|
Gillen CD, Walmsley RS, Prior P, Andrews HA and Allan RN: Ulcerative colitis and Crohn's disease: A comparison of the colorectal cancer risk in extensive colitis. Gut. 35:1590–1592. 1994. View Article : Google Scholar : PubMed/NCBI | |
|
Lv W, Li Q, Jia B, He Y, Ru Y, Guo Q, Li X and Lin W: Differentiated embryonic chondrocyte-expressed gene 1 promotes temozolomide resistance by modulating the SP1-MGMT axis in glioblastoma. Am J Transl Res. 13:2331–2349. 2021.PubMed/NCBI | |
|
Thanasupawat T, Glogowska A, Burg M, Wong GW, Hoang-Vu C, Hombach-Klonisch S and Klonisch T: RXFP1 is targeted by complement C1q tumor necrosis factor-related factor 8 in brain cancer. Front Endocrinol (Lausanne). 6:1272015. View Article : Google Scholar : PubMed/NCBI | |
|
Guo X, Liu Y, Huang X, Wang Y, Qu J and Lv Y: Serum relaxin as a diagnostic and prognostic marker in patients with epithelial ovarian cancer. Cancer Biomark. 21:81–87. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Klonisch T, Bialek J, Radestock Y, Hoang-Vu C and Hombach-Klonisch S: Relaxin-like ligand-receptor systems are autocrine/paracrine effectors in tumor cells and modulate cancer progression and tissue invasiveness. Adv Exp Med Biol. 612:104–118. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Silvertown JD, Symes JC, Neschadim A, Nonaka T, Kao JC, Summerlee AJ and Medin JA: Analog of H2 relaxin exhibits antagonistic properties and impairs prostate tumor growth. FASEB J. 21:754–65. 2007. View Article : Google Scholar : PubMed/NCBI | |
|
Klonisch T, Glogowska A, Thanasupawat T, Burg M, Krcek J, Pitz M, Jaggupilli A, Chelikani P, Wong GW and Hombach-Klonisch S: Structural commonality of C1q TNF-related proteins and their potential to activate relaxin/insulin-like family peptide receptor 1 signalling pathways in cancer cells. Br J Pharmacol. 174:1025–1033. 2017. View Article : Google Scholar : PubMed/NCBI | |
|
Thanasupawat T, Glogowska A, Burg M, Krcek J, Beiko J, Pitz M, Zhang GJ, Hombach-Klonisch S and Klonisch T: C1q/TNF-related peptide 8 (CTRP8) promotes temozolomide resistance in human glioblastoma. Mol Oncol. 12:1464–1479. 2018. View Article : Google Scholar : PubMed/NCBI | |
|
Chen L and Su G: Identification of CTRP1 as a prognostic biomarker and oncogene in human glioblastoma. Biomed Res Int. 2019:25824162019.PubMed/NCBI | |
|
Maeda T, Jikko A, Abe M, Yokohama-Tamaki T, Akiyama H, Furukawa S, Takigawa M and Wakisaka S: Cartducin, a paralog of Acrp30/adiponectin, is induced during chondrogenic differentiation and promotes proliferation of chondrogenic precursors and chondrocytes. J Cell Physiol. 206:537–544. 2006. View Article : Google Scholar : PubMed/NCBI | |
|
Qu HX, Cui L, Meng XY, Wang ZJ, Cui YX, Yu YP, Wang D and Jiang XJ: C1QTNF6 is overexpressed in gastric carcinoma and contributes to the proliferation and migration of gastric carcinoma cells. Int J Mol Med. 43:621–629. 2019.PubMed/NCBI | |
|
Wang C, Gao C, Zhuang JL, Ding C and Wang Y: A combined approach identifies three mRNAs that are down-regulated by micro RNA-29b and promote invasion ability in the breast cancer cell line MCF-7. J Cancer Res Clin Oncol. 138:2127–2136. 2012. View Article : Google Scholar : PubMed/NCBI | |
|
Zhang W and Feng G: C1QTNF6 regulates cell proliferation and apoptosis of NSCLC in vitro and in vivo. Biosci Rep. 41:BSR202015412021. View Article : Google Scholar : PubMed/NCBI | |
|
Han M, Wang B, Zhu M and Zhang Y: C1QTNF6 as a novel biomarker regulates cellular behaviors in A549 cells and exacerbates the outcome of lung adenocarcinoma patients. In Vitro Cell Dev Biol Anim. 55:614–621. 2019. View Article : Google Scholar : PubMed/NCBI |
